Board MeetingAug 4, 2026, 08:33 AM
Allogene Schedules Q2 2026 Earnings Call for August 12
AI Summary
Allogene Therapeutics, Inc. announced it will report its second quarter 2026 financial results and provide a business update on August 12, 2026, after the close of the market. This will be followed by a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET. Investors can access the listen-only webcast on the company's website, with a replay available for approximately 30 days.
Key Highlights
- Allogene Therapeutics to report Q2 2026 financial results and provide a business update.
- Conference call and webcast scheduled for August 12, 2026.
- The event will take place after market close at 2:00 p.m. PT/5:00 p.m. ET.
- Listen-only webcast available on the company's website under the Investors tab.
- Registration link provided for participants wishing to ask questions on the call.
Price Impact
More from ALLO